Reduced CD300LG mRNA tissue expression, increased intramyocellular lipid content and impaired glucose metabolism in healthy male carriers of Arg82Cys in CD300LG: A novel genometabolic cross-link between CD300LG and common metabolic phenotypes

BMJ Open Diabetes Research and Care

Volumn 3, Issue 1, 2015, Pages

  Støy, Julie ^a   Kampmann, Ulla ^a   Mengel, Annette ^b   Magnusson, Nils E ^b   Jessen, Niels ^b   Grarup, Niels ^c   Rungby, Jørgen ^b,d   Stødkilde Jørgensen, Hans ^a   Brandslund, Ivan ^e   Christensen, Cramer ^e   Hansen, Torben ^c   Pedersen, Oluf ^c   Møller, Niels ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Capital Region   (Denmark)

^d Mental Health Center Glostrup   (Denmark)

^e LILLEBAELT HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CD 300 LG; INSULIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CALORIMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; DNA POLYMORPHISM; ENERGY EXPENDITURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INSULIN SENSITIVITY; INTRAVENOUS CATHETER; LIPID STORAGE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MUSCLE BIOPSY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RESPIRATORY QUOTIENT; RESTING ENERGY EXPENDITURE; WESTERN BLOTTING;

EID: 84995606205     PISSN: None     EISSN: 20524897     Source Type: Journal    
DOI: 10.1136/bmjdrc-2015-000095     Document Type: Article

References (44)

1. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113-32.
2. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
3. Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008;32:1431-7.
4. Pan DA, Lillioja S, Milner MR, et al. Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest 1995;96:2802-8.
5. Bachmann OP, Dahl DB, Brechtel K, et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 2001;50:2579-84.
6. Korenblat KM, Fabbrini E, Mohammed BS, et al. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008;134:1369-75.
7. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36.
8. Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115:e290-6.
9. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Int J Epidemiol 2013;42:1215-22.
10. Almgren P, Lehtovirta M, Isomaa B, et al. Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia 2011;54:2811-19.
11. Andersen G, Hansen T, Pedersen O. Genetics of common forms of glycaemia with pathological impact on vascular biology: are we on the right track? Curr Mol Med 2005;5:261-74.
12. Köbberling J, Tillil H. Empirical risk figures for first-degree relatives of non-insulin dependent diabetic patients. The genetics of diabetes mellitus. London: Academic Press, 1982:201-9.
13. Pedersen O, Echwald SM. Genetics of human obesity. In: LeRoith D, Olefsky JM, Taylor SI, eds. Diabetes-a fundamental and clinical text. 3rd edn. Lippincott, Williams & Williams, 2004:827-38.
14. Kotchen TA, Kotchen JM, Grim CE, et al. Genetic determinants of hypertension: identification of candidate phenotypes. Hypertension 2000;36:7-13.
15. Tuomi T, Santoro N, Caprio S, et al. The many faces of diabetes: a disease with increasing heterogeneity. Lancet 2014;383:1084-94.
16. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707-13.
17. Scott RA, Lagou V, Welch RP, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 2012;44:991-1005.
18. Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011;478:103-9.
19. Randall JC, Winkler TW, Kutalik Z, et al. Sex-stratified genome-wide association studies including 270, 000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet 2013;9:e1003500.
20. Albrechtsen A, Grarup N, Li Y, et al. Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia 2013;56:298-310.
21. Borrego F. The CD300 molecules: an emerging family of regulators of the immune system. Blood 2013;121:1951-60.
22. Cannon JP, O'Driscoll M, Litman GW. Specific lipid recognition is a general feature of CD300 and TREM molecules. Immunogenetics 2012;64:39-47.
23. Takatsu H, Hase K, Ohmae M, et al. CD300 antigen like family member G: a novel Ig receptor like protein exclusively expressed on capillary endothelium. Biochem Biophys Res Commun 2006;348:183-91.
24. Umemoto E, Hayasaka H, Bai Z, et al. Novel regulators of lymphocyte trafficking across high endothelial venules. Crit Rev Immunol 2011;31:147-69.
25. Stoy J, Grarup N, Horlyck A, et al. Blood pressure levels in male carriers of Arg82Cys in CD300LG. PLoS ONE 2014;9: e109646.
26. Tripathy D, Wessman Y, Gullstrom M, et al. Importance of obtaining independent measures of insulin secretion and insulin sensitivity during the same test: results with the Botnia clamp. Diabetes Care 2003;26:1395-401.
27. Moller N, Butler PC, Antsiferov MA, et al. Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 1989;32:105-10.
28. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 1959;82:420-30.
29. Debodo RC, Steele R, Altszuler N, et al. On the hormonal regulation of carbohydrate metabolism; studies with C14 GLUCOSE. Recent Prog Horm Res 1963;19:445-88.
30. Radziuk J, Norwich KH, Vranic M. Experimental validation of measurements of glucose turnover in nonsteady state. Am J Physiol 1978;234:E84-93.
31. Nielsen S, Guo Z, Johnson CM, et al. Splanchnic lipolysis in human obesity. J Clin Invest 2004;113:1582-8.
32. Jensen MD, Rogers PJ, Ellman MG, et al. Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. Am J Physiol 1988;254(5 Pt 1):E562-5.
33. Jensen MD. Regulation of forearm lipolysis in different types of obesity. In vivo evidence for adipocyte heterogeneity. J Clin Invest 1991;87:187-93.
34. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
35. Maersk M, Belza A, Stodkilde-Jorgensen H, et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr 2012;95:283-9.
36. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-9.
37. Orskov H, Thomsen HG, Yde H. Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 1968;219:193-5.
38. Thiel S, Moller-Kristensen M, Jensen L, et al. Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Immunobiology 2002;205:446-54.
39. Krzywinski M, Altman N. Visualizing samples with box plots. Nat Methods 2014;11:119-20.
40. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med 2014;371:1131-41.
41. Dube JJ, Amati F, Toledo FG, et al. Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. Diabetologia 2011;54: 1147-56.
42. Moro C, Galgani JE, Luu L, et al. Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals. J Clin Endocrinol Metab 2009;94:3440-7.
43. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985;6:45-86.
44. Hermans MP, Levy JC, Morris RJ, et al. Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 1999;48:1779-86.